HINT1 inhibits beta-catenin/TCF4, USF2 and NFkappaB activity in human hepatoma cells

Lin Wang1, Haiyang Li, Yujing Zhang

  • 1Department of Hepatobiliary Surgery, Kunming Medical College, Kunming, China.

Insights

The tumor suppressor gene HINT1 (HINT1) is downregulated in some human hepatoma cells due to epigenetic silencing. Restoring HINT1 expression inhibits hepatoma cell growth by affecting key transcription factors.

Area of Science:

  • Hepatocellular carcinoma research
  • Epigenetics and cancer biology
  • Tumor suppressor gene function

Background:

  • Hepatocellular carcinoma (HCC) is a major global health concern.
  • The role of novel tumor suppressor genes in HCC pathogenesis requires further elucidation.
  • Epigenetic alterations, such as DNA methylation, are implicated in cancer development.

Purpose of the Study:

  • To investigate the relevance of the novel tumor suppressor gene, HINT1, in human hepatoma.
  • To explore the mechanisms of HINT1 regulation and its functional impact on hepatoma cells.

Main Methods:

  • Analysis of HINT1 protein and mRNA expression in human hepatoma cell lines (Hep3B, HepG2, Huh7).
  • Assessment of Hint1 promoter methylation status and the effect of 5-aza-2'-deoxycytidine (5-azadcdeoxycytidine) treatment.
  • Evaluation of HINT1's impact on cell proliferation, transcriptional activities (beta-catenin/TCF4, USF2, NFkappaB), and target gene expression (cyclin D1, TGFbeta2).
  • Co-immunoprecipitation assays to determine protein interactions (HINT1 and USF2).

Main Results:

  • Hep3B and HepG2 cells exhibited low HINT1 protein levels, correlating with partial promoter methylation, unlike Huh7 cells.
  • 5-azadcdeoxycytidine treatment reactivated HINT1 expression in Hep3B and HepG2 cells.
  • Re-expression of HINT1 in HepG2 cells significantly inhibited cell growth.
  • HINT1 suppressed the transcriptional activity of beta-catenin/TCF4, USF2, and NFkappaB, reducing cyclin D1 and TGFbeta2 expression.
  • HINT1 was found to co-immunoprecipitate with USF2 and inhibit NFkappaB p65 nuclear translocation.

Conclusions:

  • Epigenetic silencing of the Hint1 gene contributes to the enhanced growth of a subset of human hepatomas.
  • Decreased HINT1 expression promotes hepatoma growth by upregulating genes controlled by beta-catenin, USF2, and NFkappaB transcription factors.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...